Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sheng‐Huan Wei"'
Autor:
Chin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei, Yun-Tse Chou, Chian-Wei Chen, Jeng-Shiuan Tsai, Po-Lan Su, Chien-Chung Lin
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Invasive pulmonary aspergillosis (IPA) can negatively impact cancer patients’ survival. It remains uncertain whether IPA’s impact on patient outcomes varies by treatment approach in advanced lung cancer. Objectives: To explore the ass
Externí odkaz:
https://doaj.org/article/e5f40e36b0f44c21a944f1256d1f3e63
Autor:
Tang-Hsiu Huang, Sheng-Huan Wei, Hung-I Kuo, Hsin-Yu Hou, Chin-Wei Kuo, Yau-Lin Tseng, Sheng-Hsiang Lin, Chao-Liang Wu
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 402 (2024)
Mucin-1 is a multi-functional glycoprotein expressed by type II alveolocytes and may be detectable in the circulation following pulmonary fibrosis. The prognostic utility of baseline pre-treatment blood levels of mucin-1 in patients with idiopathic p
Externí odkaz:
https://doaj.org/article/2274ca7774a24f428dec0a7e2f809ad5
Autor:
Tang-Hsiu Huang, Sheng-Huan Wei, Li-Ting Huang, Hong-Ping Er, Yu-Ting Yu, Chung-Ta Lee, Yau-Lin Tseng, Chao-Liang Wu
Publikováno v:
ERJ Open Research, Vol 9, Iss 1 (2023)
Background Organising pneumonia (OP) has variable clinical and radiographic presentations and unstandardised treatments. Most patients with OP have favourable outcomes, but some develop respiratory insufficiency, experience recurrence or die. In this
Externí odkaz:
https://doaj.org/article/f4a934ac430f439489f89553fe76ba5a
Autor:
Chien-Yu Lin, Sheng-Huan Wei, Yi-Lin Chen, Chung-Ta Lee, Shang-Yin Wu, Chung-Liang Ho, Dean C. Pavlick, Po-Lan Su, Chien-Chung Lin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Telisotuzumab vedotin is a MET-targeting antibody–drug conjugate that has demonstrated a good treatment response in patients with EGFR wild-type MET-overexpressing non-squamous non-small cell lung cancer. However, patients have been reported to acq
Externí odkaz:
https://doaj.org/article/c5d82a14666246079097088647b395c1
Publikováno v:
Respirology Case Reports, Vol 10, Iss 7, Pp n/a-n/a (2022)
Abstract Patients with chronic bronchiectasis are susceptible to various respiratory complications. In this report, however, we describe a 53‐year‐old male with chronic bronchiectasis who developed extensive but asymptomatic jejuno‐ileal pneuma
Externí odkaz:
https://doaj.org/article/e425917421d743a68f61ba39b678c5dc
Autor:
Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1407 (2022)
The use of immune checkpoint inhibitors (ICIs) has provided overall survival (OS) benefits in patients with treatment-naïve advanced non-small cell lung cancer (NSCLC) without targetable driver mutations. However, studies comparing ICIs monotherapy
Externí odkaz:
https://doaj.org/article/22fa43d48459485ea5cdf796ce0f8c31
Autor:
Tang-Hsiu Huang, Sheng-Huan Wei, Li-Ting Huang, Hong-Ping Er, Yu-Ting Yu, Chung-Ta Lee, Yau-Lin Tseng, Chao-Liang Wu
Publikováno v:
ERJ Open Research. 9:00505-2022
BackgroundOrganising pneumonia (OP) has variable clinical and radiographic presentations and unstandardised treatments. Most patients with OP have favourable outcomes, but some develop respiratory insufficiency, experience recurrence or die. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3d4794be71c9817281d3be7fcf433e9
https://doi.org/10.1183/23120541.00505-2022
https://doi.org/10.1183/23120541.00505-2022